192.30
-2.00
(-1.03%)
At close: January 22 at 6:38:19 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Feb 2025) | Next Qtr. (May 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Feb 2025) | Next Qtr. (May 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 11 | 11 | 16 | 16 |
| Avg. Estimate | 2.6B | 2.63B | 10.27B | 11.03B |
| Low Estimate | 2.58B | 2.62B | 9.94B | 10.92B |
| High Estimate | 2.61B | 2.66B | 10.32B | 11.13B |
| Year Ago Sales | 2.41B | 2.47B | 9.6B | 10.27B |
| Sales Growth (year/est) | 7.97% | 6.60% | 7.06% | 7.39% |
EPS Trend
| Currency in USD | Current Qtr. (Feb 2025) | Next Qtr. (May 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Feb 2025) | Next Qtr. (May 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CIT.F | -- | -- | -- | -- |
| S&P 500 | 9.39% | 11.29% | 14.06% | 13.54% |
Upgrades & Downgrades
| Maintains | Goldman Sachs: Buy to Buy | 12/20/2024 |
| Maintains | Truist Securities: Buy to Buy | 12/20/2024 |
| Maintains | UBS: Buy to Buy | 12/20/2024 |
| Reiterates | RBC Capital: Sector Perform to Sector Perform | 12/20/2024 |
| Maintains | Wells Fargo: Underweight to Underweight | 12/20/2024 |
| Maintains | Baird: Neutral to Neutral | 12/20/2024 |